Answers are grounded in this paper and cite their sources.
Treatment-induced neuropathy of diabetes (TIND) is a rare but challenging complication of rapid glycemic control, presenting as severe neuropathic pain and often refractory to conventional treatments. We herein report a case of a 17-year-old female with type 1 diabetes with severe bilateral lower limb pain (visual analog scale: 8/10) after rapid glycemic improvement (hemoglobin A1C: 12.8% to 9.9%). Conventional treatments, including gabapentin, duloxetine, nerve blocks, and transcutaneous electrical nerve stimulation, provided minimal relief. The introduction of carbamazepine led to significant symptom improvement, highlighting its effectiveness in managing TIND. Effective management strategies are limited, necessitating the exploration of alternative therapeutic options.
No takes yet. Share an insight, caveat, or question.
Saini et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: